| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/2000 | US6048974 Nucleotide sequences that serve as clamps for preferentially binding to target polynucleotides forming stable circular structures |
| 04/11/2000 | US6048973 Nucleotide sequences that induce expession of a rice enzyme during glucose depletion |
| 04/11/2000 | US6048972 Polynucleotide sequences which code for reshaped human monoclonal antibody preferential to interleukins |
| 04/11/2000 | US6048971 Recombinant human erythropoietin mutants |
| 04/11/2000 | US6048970 Prostate growth-associated membrane proteins |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048964 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 04/11/2000 | US6048962 Mammalian protein allergen; for the diagnosis and treatment of mammalian allergic response |
| 04/11/2000 | US6048839 Materials and methods for controlling insect pests with pesticidal proteins obtainable from Bacillus thuringiensis isolates PS158C2 and HD511 |
| 04/11/2000 | US6048837 Dietetics |
| 04/11/2000 | US6048731 Deoxyribonucleic acid coding for a streptomyces griseus restriction endonuclease |
| 04/11/2000 | US6048730 Selectable marker for development of vectors and transformation systems in plants |
| 04/11/2000 | US6048729 Animal transfected clonal cells for the expression of therapeutic products |
| 04/11/2000 | US6048726 Oligonucleotide which suppresses gene expression; for the treatment of inflammatory diseases, skin disorders and asthma |
| 04/11/2000 | US6048725 Genetically engineered cancer cell line; for producing recombinant viral vectors and packaging cells |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048719 Deoxyribonucleic acid coding for a restriction enzyme |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048713 Pseudomonas fluorescens |
| 04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
| 04/11/2000 | US6048710 Vector comprising nucleic acid coding a kinase; for the production and secretion of proteins in cells |
| 04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
| 04/11/2000 | US6048698 Producing products by bond formation of a reactant bound to nucleic acid and a free reactant, then contacting product library with target to partition products by ability to perform preselected function |
| 04/11/2000 | US6048697 Nucleotide sequences which preferentially hybridizes to and amplifies specific nucleotide sequences; for the isolation and detection of specific bacteria |
| 04/11/2000 | US6048695 Nucleic acid modified by addition of epoxide-alkoxysilane compound for immobilization to unmodified or underivatized glass surface; for hybridization microarrays for genome-wide genetic mapping and gene expression studies |
| 04/11/2000 | US6048694 Screening for gram positive bacterial transformed with heterologus nucleic acids; constructing vector and inserting nucleic acids, destroying enzyme activity, transforming cell defective in sucrose metabolism, isolating transformant |
| 04/11/2000 | US6048693 Screening for modulators of mammalian cell cycle regulatory proteins; administering a compound to a cell line and analyzing the expression of a reporter gene in the cell line, thereby determining whether the compound affects normal |
| 04/11/2000 | US6048692 Sensors for electrically sensing binding events for supported molecular receptors |
| 04/11/2000 | US6048691 Separating multiple sample fragments into subsamples; applying the first subsample to a binding assay for detecting four nucleotide sequences, applying the second subsample to a binding assay for detecting four nucleotide sequences |
| 04/11/2000 | US6048687 Detecting nucleotide sequence; obtaining sample, mixing sample with reagent, incubating sample with reaction mixture to amplify nucleotide sequence, obtaining samples, adding probe, incubating with second mixture and detecting complex |
| 04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
| 04/11/2000 | US6048527 Non-autoreactive; n-propionylated neisseria serogroup b capsular polysaccharide-protein conjugates |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/11/2000 | CA2220729C Method for refolding insoluble aggregates of hepatitis c virus protease |
| 04/11/2000 | CA2009579C Insulin analogs |
| 04/11/2000 | CA2002776C Detection of human papillomavirus dna and its expression in cervical smears |
| 04/11/2000 | CA1340953C Non-tumorigenic cell lines for expression of genes |
| 04/09/2000 | CA2639757A1 Amino acid modified polypeptides |
| 04/09/2000 | CA2639637A1 Amino acid modified polypeptides |
| 04/09/2000 | CA2639620A1 Amino acid modified polypeptides |
| 04/09/2000 | CA2284117A1 Process for the preparation of pantothenic acid by amplification of nucleotide sequences which code for ketopantoate reductase |
| 04/07/2000 | CA2246623A1 Oligonucleotide primers that destabilize non-specific duplex formation and reduce mispriming during cdna library construction and uses thereof |
| 04/06/2000 | WO2000018970A1 Method for controlling the release of granules |
| 04/06/2000 | WO2000018968A1 An in vitro activity assay for human hepatitis b virus (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase |
| 04/06/2000 | WO2000018967A1 A method for analyzing polynucleotides |
| 04/06/2000 | WO2000018965A1 Multiplex genotyping using fluorescent hybridization probes |
| 04/06/2000 | WO2000018964A1 Identification of virulence determinant activators in prokaryotic pathogens |
| 04/06/2000 | WO2000018963A1 Methods for breeding for and screening of soybean plants with enhanced yields, and soybean plants with enhanced yields |
| 04/06/2000 | WO2000018962A1 Methods and compositions for amplifying detectable signals in specific binding assays |
| 04/06/2000 | WO2000018961A2 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 04/06/2000 | WO2000018960A2 Methods and products related to genotyping and dna analysis |
| 04/06/2000 | WO2000018959A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | WO2000018958A2 An in vitro activity assay for human hepatits b virus (hbv) dna polymerase, the use of such an assay to assay activity of various serum samples and to screen for inhibitors of the hbv dna polymerase and a method of producing hbv dna polymerase |
| 04/06/2000 | WO2000018957A1 Methods of nucleic acid amplification and sequencing |
| 04/06/2000 | WO2000018956A1 Method for dna- or rna-sequencing |
| 04/06/2000 | WO2000018954A2 Use of pex in the treatment of metabolic bone diseases |
| 04/06/2000 | WO2000018952A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 04/06/2000 | WO2000018941A1 Mammalian artificial chromosomes and uses thereof |
| 04/06/2000 | WO2000018940A1 Plants and plants cells encoding the wild type cop1 gene and the coil domain thereof |
| 04/06/2000 | WO2000018939A1 Method of plant transformation |
| 04/06/2000 | WO2000018938A1 Mar/sar elements flanking rsyn7-driven construct |
| 04/06/2000 | WO2000018937A1 Maize glutathione-s-transferase enzymes |
| 04/06/2000 | WO2000018936A1 Soybean glutathione-s-transferase enzymes |
| 04/06/2000 | WO2000018935A1 Process for constructing amino acid-producing bacterium and process for producing amino acid by fermentation method with the use of the thus constructed amino acid-producing bacterium |
| 04/06/2000 | WO2000018934A1 Peptidyl prolyl cis-trans isomerases |
| 04/06/2000 | WO2000018932A2 Receptor based antagonists and methods of making and using |
| 04/06/2000 | WO2000018931A1 Novel enzyme compositions, process for producing the same and utilization of the same |
| 04/06/2000 | WO2000018930A1 Plant promoter |
| 04/06/2000 | WO2000018929A2 Paramyxovirus vaccines |
| 04/06/2000 | WO2000018928A1 Treatment of wilt diseases |
| 04/06/2000 | WO2000018927A1 Improved starchy flours |
| 04/06/2000 | WO2000018926A1 USE OF BIFUNCTIONAL α-AMYLASE SUBTILISIN INHIBITOR PROMOTER SEQUENCE OF BARLEY TO CONFER EXPRESSION IN SEEDS |
| 04/06/2000 | WO2000018925A1 Gene expressed in prostate cancer |
| 04/06/2000 | WO2000018924A1 Human small proline-rich molecule |
| 04/06/2000 | WO2000018923A2 Slgp protein and nucleic acid molecule and uses therefor |
| 04/06/2000 | WO2000018922A2 Human carbohydrate-associated proteins |
| 04/06/2000 | WO2000018921A2 Synthetic peptides having fgf receptor affinity |
| 04/06/2000 | WO2000018920A2 Tmof receptor and uses thereof |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | WO2000018917A2 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION |
| 04/06/2000 | WO2000018916A2 Human genes and gene expression products |
| 04/06/2000 | WO2000018915A2 Membrane-associated organizational proteins |
| 04/06/2000 | WO2000018914A2 Novel dkr polypeptides |
| 04/06/2000 | WO2000018913A1 Apc-2 |
| 04/06/2000 | WO2000018912A2 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | WO2000018911A1 New gene which is down-regulated in large intestine cancer |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018909A2 NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) |
| 04/06/2000 | WO2000018908A1 Use of specific hybrid promoters for controlling tissue expression |
| 04/06/2000 | WO2000018907A2 Antisense-sequences for inhibiting the expression of the adhesion molecule icam-1 |
| 04/06/2000 | WO2000018906A2 Shuffling of codon altered genes |
| 04/06/2000 | WO2000018905A1 Method of producing permuteins by scanning permutagenesis |
| 04/06/2000 | WO2000018903A2 Inducible genetic suppression of cellular excitability |
| 04/06/2000 | WO2000018902A1 Method of screening for large offspring syndrome |
| 04/06/2000 | WO2000018900A1 Dnas encoding novel polypeptides |
| 04/06/2000 | WO2000018899A2 Angiotensin converting enzyme homolog and its use |
| 04/06/2000 | WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2000 | WO2000018889A2 Sequenzes of putative plant acyltransferases |